Atopic conjunctivitis

H7_CONJUNCTIVITISATOPIC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H10.1 Cause of death: ICD-10 — H10.1 2 out of 7 registries used, show all original rules.	1791
4. Check minimum number of events None	1791
5. Include endpoints None	1791
6. Filter based on genotype QC (FinnGen only)	1791

Control definitions (FinnGen only)

Control exclude: H7_CONJUNCTIVA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H10
Name in latin: Conjunctivitis allergica acuta

NAME	H7_CONJUNCTIVITISATOPIC
CONTROL_EXCLUDE	H7_CONJUNCTIVA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H101
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H101
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Atopic conjunctivitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	18915	10051	8786
Only index persons	16337	9105	7232
Unadjusted period prevalence (%)
Whole population	0.27	0.29	0.25
Only index persons	0.31	0.33	0.28
Median age at first event (years)
Whole population	21.79	30.09	12.19
Only index persons	25.18	32.97	15.38

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1791	1279	512
Unadjusted period prevalence (%)	0.38	0.44	0.23
Median age at first event (years)	41.61	42.78	38.68

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1594: Matched controls
15940

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S01GX01

ATC

cromoglicic acid; ophthalmic

12.4

323.0

852

1347

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

4503599627370496.0

323.0

1593

108

S01GX08

ATC

ketotifen; ophthalmic

16.1

125.3

210

149

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

3.5

114.5

787

3478

H04.10

ICD-10 Finland

Dry eye syndrome

6.2

106.4

318

620

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

3.5

102.0

648

2631

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

7.2

98.3

256

411

R06AE07

ATC

cetirizine; oral

3.1

97.4

929

4993

R06AX27

ATC

desloratadine; oral

3.0

82.0

646

2943

S01GX09

ATC

olopatadine; ophthalmic

16.9

80.6

131

S01GX02

ATC

levocabastine; ophthalmic

7.7

79.2

195

284

J45.0

ICD-10 Finland

Predominantly allergic asthma

4.9

78.5

284

675

E0000UV

ATC

2.7

73.4

797

4346

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

6.9

71.0

188

303

H02AB06

ATC

prednisolone; systemic

2.5

63.6

799

4593

L20.0

ICD-10 Finland

Besnier prurigo

4.3

62.8

257

681

R06AE09

ATC

levocetirizine; oral

3.3

62.4

366

1314

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

3.9

61.0

280

823

R03AC02

ATC

salbutamol; inhalant

2.4

60.4

963

6198

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

6.1

59.2

172

312

H10.4

ICD-10 Finland

Chronic conjunctivitis

109.3

58.3

S01GX05

ATC

lodoxamide; ophthalmic

47.2

55.9

R06AX22

ATC

ebastine; oral

3.0

54.1

360

1395

R06AX13

ATC

loratadine; oral

3.0

53.3

351

1351

C01CA24

ATC

epinephrine; parenteral

4.5

52.8

202

497

XQ800

NOMESCO Finland

Prick test

3.9

52.4

239

693

R03DC03

ATC

montelukast; oral

3.0

50.8

353

1401

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.0

50.3

348

1378

R01AD09

ATC

mometasone; nasal

2.2

50.2

831

5246

S01GX06

ATC

emedastine; ophthalmic

22.5

47.4

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

4.7

46.2

166

382

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.7

45.5

366

1582

R01AD08

ATC

fluticasone; nasal

2.3

43.7

515

2723

J30.3

ICD-10 Finland

Other allergic rhinitis

5.7

42.3

128

242

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

6.8

42.3

110

171

E000001

ATC

2.4

41.4

417

2025

Z51.6

ICD-10 Finland

Desensitization to allergens

14.2

41.3

D07AA02

ATC

hydrocortisone; topical

2.7

40.3

320

1359

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

39.4

341

1519

H01.0

ICD-10 Finland

Blepharitis

4.4

38.8

148

360

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

5.9

38.5

112

202

R03BA05

ATC

fluticasone; inhalant

2.5

38.0

357

1663

D07AC13

ATC

mometasone; topical

2.2

36.8

490

2698

XQ802

NOMESCO Finland

Epicutan test

4.8

36.2

127

284

R01AD12

ATC

fluticasone furoate; nasal

2.1

35.2

563

3338

R03BA02

ATC

budesonide; inhalant

2.4

34.6

332

1555

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.2

34.4

199

685

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

9.5

33.5

R06AX26

ATC

fexofenadine; oral

3.6

32.2

153

452

E000002

ATC

2.6

32.1

254

1067

S01AD03

ATC

aciclovir; ophthalmic

5.8

31.0

162

D07AB02

ATC

hydrocortisone butyrate; topical

2.0

30.3

468

2698

S01GX04

ATC

nedocromil; ophthalmic

10.9

29.6

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

2.1

28.9

406

2248

T78.4

ICD-10 Finland

Allergy, unspecified

3.8

28.9

129

362

R03BA01

ATC

beclometasone; inhalant

2.5

27.5

243

1078

D07AC01

ATC

betamethasone; topical

1.9

27.0

513

3175

R01AD01

ATC

beclometasone; nasal

2.4

27.0

259

1198

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.6

26.8

216

910

D11AH01

ATC

tacrolimus; topical

11.4

26.7

J01AA02

ATC

doxycycline; systemic

1.8

26.4

1134

9156

R03AC03

ATC

terbutaline; inhalant

2.4

26.3

251

1158

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

26.2

822

5993

J01DB01

ATC

cefalexin; oral

1.9

25.4

1292

10966

F03

ICPC

Eye discharge

3.1

25.3

146

499

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

24.4

413

2434

J01FA10

ATC

azithromycin; systemic

1.7

24.2

1011

7959

D07AB08

ATC

desonide; topical

2.5

24.2

200

851

J45

ICD-10 Finland

Asthma

2.7

23.9

180

728

D11AX14

ATC

[U] tacrolimus; topical

17.2

23.6

D11AH02

ATC

pimecrolimus; topical

21.7

23.5

H57.1

ICD-10 Finland

Ocular pain

4.5

23.4

197

XCK00

NOMESCO Finland

Perimetry

3.5

23.4

115

349

R96

ICPC

Asthma

2.8

23.4

164

636

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

22.9

592

4012

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

4.0

22.7

242

H02AB04

ATC

methylprednisolone; systemic

2.3

22.3

229

1091

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.3

21.6

220

1040

R06.0

ICD-10 Finland

Dyspnoea

1.9

21.1

349

2023

S01EA05

ATC

brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)

6.5

21.1

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

3.7

20.4

266

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.3

20.3

207

979

114

Kela drug reimbursment

Glaucoma

3.2

19.5

108

359

R03AK07

ATC

formoterol and budesonide; inhalant

2.0

19.3

296

1664

E000003

ATC

3.4

19.2

296

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

4.4

19.0

161

Z71.8

ICD-10 Finland

Other specified counselling

1.8

18.9

406

2564

H10.5

ICD-10 Finland

Blepharoconjunctivitis

7.2

18.7

N05BB01

ATC

hydroxyzine; systemic

2.7

18.6

129

495

WQ000

NOMESCO Finland

Hyposensibilisation

12.5

18.6

H16.0

ICD-10 Finland

Corneal ulcer

3.3

18.2

308

H16.2

ICD-10 Finland

Keratoconjunctivitis

14.5

18.1

A02BC03

ATC

lansoprazole; oral

1.8

18.0

391

2469

H10

ICD-10 Finland

Conjunctivitis

2.7

17.8

126

491

R51.80

ICD-10 Finland

Headache

1.9

17.8

277

1561

Z3231

NOMESCO Finland

Registered nurse

1.7

17.4

396

2535

J01DA01

ATC

[U] cefalexin; systemic

1.6

17.4

935

7532

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

17.2

271

1534

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

17.2

349

2154

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

17.0

426

2805

F29

ICPC

Eye symptom/complaint other

2.4

16.9

147

640

S01ED01

ATC

timolol; ophthalmic

4.7

16.9

128

S01AX11

ATC

[U] ofloxacin; ophthalmic

4.2

16.9

156

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

16.9

270

1536

R05

ICD-10 Finland

Cough

1.9

16.8

293

1717

M79.6

ICD-10 Finland

Pain in limb

1.6

16.7

517

3613

S01ED51

ATC

timolol, combinations; ophthalmic

3.1

16.5

324

A02BC02

ATC

pantoprazole; systemic

1.6

16.5

875

6979

Z00.0

ICD-10 Finland

General medical examination

1.8

16.5

296

1752

J01FA06

ATC

roxithromycin; oral

1.6

16.4

573

4124

A02BC05

ATC

esomeprazole; systemic

1.6

16.4

550

3916

H20.1

ICD-10 Finland

Chronic iridocyclitis

9.3

16.2

M25.5

ICD-10 Finland

Pain in joint

1.7

15.9

429

2878

E000006

ATC

2.5

15.8

131

556

J01FA09

ATC

clarithromycin; systemic

1.6

15.8

490

3414

S01EC04

ATC

brinzolamide; ophthalmic

4.3

15.6

139

E000007

ATC

2.6

15.6

116

466

R42

ICD-10 Finland

Dizziness and giddiness

1.8

15.6

288

1720

S01EE01

ATC

latanoprost; ophthalmic

3.3

15.5

243

M54.5

ICD-10 Finland

Low back pain

1.6

15.3

488

3419

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

15.0

375

2453

N03AX12

ATC

gabapentin; oral

2.0

15.0

216

1178

A92

ICPC

Allergy/allergic reaction NOS

3.6

15.0

195

F02

ICPC

Red eye

3.0

14.8

290

H11.4

ICD-10 Finland

Other conjunctival vascular disorders and cysts

57.2

14.8

H15.1

ICD-10 Finland

Episcleritis

5.4

14.3

J01FF01

ATC

clindamycin; systemic

1.7

14.2

373

2467

S01EX03

ATC

6.6

14.2

D07CC01

ATC

betamethasone and antibiotics; topical

2.0

14.1

195

1046

S01EC03

ATC

dorzolamide; ophthalmic

8.1

14.1

D07AD01

ATC

clobetasol; topical

1.9

14.0

211

1168

H02AB07

ATC

prednisone; oral

2.0

14.0

196

1056

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

14.0

365

2413

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.9

14.0

211

1169

ZYC01

NOMESCO Finland

Remote contact by phone

2.9

13.9

309

N02BE01

ATC

paracetamol; systemic, rectal

1.6

13.9

1255

11111

J45.8

ICD-10 Finland

Mixed asthma

3.7

13.9

171

S01EC01

ATC

acetazolamide; systemic

5.1

13.9

R01AC01

ATC

cromoglicic acid; nasal

3.3

13.8

225

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

13.8

258

1541

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

13.8

617

4665

L27.2

ICD-10 Finland

Dermatitis due to ingested food

5.2

13.7

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

13.7

244

1436

H11.1

ICD-10 Finland

Conjunctival degenerations and deposits

+∞

13.6

R02

ICPC

Shortness of breath/dyspnoea

2.0

13.5

173

899

R74

ICPC

Upper respiratory infection acute

1.5

13.4

523

3824

D02AE01

ATC

carbamide; topical

2.4

13.3

114

494

R01AD11

ATC

triamcinolone; nasal

2.2

13.3

134

630

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

5.5

13.2

XCC00

NOMESCO Finland

Investigative irrigation of lacrimal passages

6.3

13.1

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.3

13.0

127

587

J05AB01

ATC

aciclovir; systemic

1.7

12.9

318

2065

N02AX02

ATC

tramadol; systemic, rectal

1.5

12.8

515

3779

J30.19

ICD-10 Finland

Pollen allergy UNS

3.4

12.7

184

R03BA08

ATC

ciclesonide; inhalant

2.3

12.7

125

580

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

12.6

301

1933

H10.2

ICD-10 Finland

Other acute conjunctivitis

6.0

12.6

F01

ICPC

Eye pain

3.4

12.6

186

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

4.5

12.5

101

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.4

12.5

111

490

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

12.5

749

5990

R06AX12

ATC

terfenadine; oral

2.9

12.3

262

M03BX02

ATC

tizanidine; oral

1.5

12.3

889

7374

S01XA18

ATC

ciclosporin; ophthalmic

16.0

12.1

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

12.0

307

2004

ZXA10

NOMESCO Finland

Bilateral

1.7

12.0

246

1509

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

5.6

12.0

D02AX

ATC

Other emollients and protectives

2.8

11.9

274

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

2.6

11.9

359

S01EA03

ATC

apraclonidine; ophthalmic

10.6

11.8

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

11.7

794

6477

R01AD05

ATC

budesonide; nasal

2.3

11.7

111

508

S18

ICPC

Laceration/cut

1.5

11.7

541

4084

RD211

NOMESCO Finland

2.8

11.6

266

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

6.9

11.6

S01BA07

ATC

fluorometholone; ophthalmic (corticosteroids, plain)

4.9

11.6

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.3

11.5

110

506

S01BC03

ATC

diclofenac; ophthalmic

4.4

11.4

WZC30

NOMESCO Finland

Teaching

1.9

11.4

171

945

S01EE05

ATC

tafluprost; ophthalmic

4.0

11.4

111

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

11.4

114

535

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.0

11.3

141

726

L04AA01

ATC

[U] ciclosporin; systemic

5.6

11.3

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

11.3

1115

9760

D11AX15

ATC

[U] pimecrolimus; topical

15.1

11.3

N03AX16

ATC

pregabalin; oral

1.6

11.3

301

1986

J46

ICD-10 Finland

Status asthmaticus

3.5

11.3

148

J02AC01

ATC

fluconazole; systemic

1.5

11.2

612

4763

N05CF01

ATC

zopiclone; oral

1.6

11.2

382

2684

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

12.8

11.1

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

8.1

11.1

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

8.1

11.1

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

11.0

125

617

R97

ICPC

Allergic rhinitis

3.7

10.8

127

M79.1

ICD-10 Finland

Myalgia

1.8

10.7

193

1134

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

4.5

10.6

SPAT1260

SPAT

Consultation of another employee

1.6

10.5

266

1728

TQW80

NOMESCO Finland

Local dermatologic skincare

3.4

10.5

151

SPAT1310

SPAT

Counselling related to known health issue

1.5

10.5

483

3620

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

10.4

297

1993

R06AX18

ATC

acrivastine; oral

3.6

10.4

132

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

10.3

605

4759

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

10.3

381

2724

J05AB11

ATC

valaciclovir; oral

1.8

10.2

180

1052

C07AB07

ATC

bisoprolol; oral

1.5

10.1

484

3648

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

10.1

473

3550

R03AC13

ATC

formoterol; inhalant

2.7

10.1

251

WX110

NOMESCO Finland

Local anesthesy

1.4

10.1

1064

9311

A01

ICPC

Pain general/multiple sites

2.1

10.1

108

523

S01ED02

ATC

betaxolol; ophthalmic

10.1

10.0

SPAT1312

SPAT

General health counselling

1.5

10.0

522

4006

N06AX11

ATC

mirtazapine; oral

1.5

10.0

424

3119

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.8

10.0

238

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

9.9

385

2778

A46

ICD-10 Finland

Erysipelas

1.9

9.9

149

822

SDA02

NOMESCO Finland

Parodonthologic therapy

1.5

9.9

488

3705

M01AH01

ATC

celecoxib; oral (coxibs)

1.7

9.9

212

1316

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

9.8

265

1749

A01AB09

ATC

miconazole; local oral

2.0

9.8

123

635

L01

ICPC

Neck symptom/complaint

1.7

9.8

202

1239

R01AC02

ATC

levocabastine; nasal

3.5

9.8

133

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

9.8

290

1965

SPAT1263

SPAT

Sampling

1.4

9.8

633

5059

M48.0

ICD-10 Finland

Spinal stenosis

2.0

9.7

124

645

R05

ICPC

Cough

1.5

9.6

337

2374

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

9.6

254

1668

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

9.6

242

1570

G44.2

ICD-10 Finland

Tension-type headache

1.7

9.6

206

1277

S01KA02

ATC

hypromellose; ophthalmic

5.1

9.6

A02BC01

ATC

omeprazole; systemic

1.5

9.6

344

2436

R83

ICPC

Respiratory infection other

1.5

9.5

421

3119

L17

ICPC

Foot/toe symptom/complaint

1.5

9.5

339

2400

L03

ICPC

Low back symptom/complaint

1.5

9.4

342

2427

H11.0

ICD-10 Finland

Pterygium

+∞

9.4

J01DA06

ATC

[U] cefuroxime; systemic

1.7

9.4

193

1182

H40.0

ICD-10 Finland

Glaucoma suspect

2.2

9.4

423

R53

ICD-10 Finland

Malaise and fatigue

1.6

9.4

273

1840

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.8

9.3

S01BC05

ATC

ketorolac; ophthalmic

3.2

9.3

150

R21

ICPC

Throat symptom/complaint

1.5

9.3

372

2696

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

9.3

431

N01

ICPC

Headache

1.7

9.2

211

1333

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

9.2

130

701

L20

ICD-10 Finland

Atopic dermatitis

2.9

9.2

184

SPAT1360

SPAT

Extensive global examination

2.1

9.1

483

D07BC01

ATC

betamethasone and antiseptics; topical

1.8

9.1

148

841

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

9.1

113

581

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

9.1

182

1105

H01.1

ICD-10 Finland

Noninfectious dermatoses of eyelid

11.5

9.1

S29

ICPC

Skin symptom/complaint other

1.6

9.1

229

1485

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

3.3

9.1

131

M01AH05

ATC

etoricoxib; oral

1.4

9.0

794

6664

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

8.9

355

2564

E000004

ATC

3.5

8.9

117

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.3

8.8

366

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

8.7

111

578

H10.8

ICD-10 Finland

Other conjunctivitis

7.2

8.7

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

7.2

8.7

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.9

8.7

180

H19.1

ICD-10 Finland

Herpesviral keratitis and keratoconjunctivitis

14.1

8.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

8.7

505

3934

S06.0

ICD-10 Finland

Concussion

1.8

8.7

155

908

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

8.7

508

3961

F70

ICPC

Conjunctivitis infectious

3.0

8.6

159

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

8.6

118

634

C07AA05

ATC

propranolol; systemic

1.5

8.5

275

1895

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

8.5

207

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

8.5

226

1487

M79.7

ICD-10 Finland

Fibromyalgia

2.7

8.4

218

A02BA02

ATC

ranitidine; systemic

1.6

8.4

224

1475

H16.9

ICD-10 Finland

Keratitis, unspecified

3.8

8.3

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

8.2

363

2677

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

8.2

116

627

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

8.1

114

615

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

8.1

439

3367

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

8.1

426

3254

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

8.0

179

1121

SPAT1216

SPAT

Assessment of functional ability

1.7

8.0

166

1017

R03AC12

ATC

salmeterol; inhalant

2.8

8.0

189

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

3.0

8.0

150

CHD00

NOMESCO Finland

Laser trabeculoplasty

5.9

8.0

J01CA04

ATC

amoxicillin; systemic

1.4

8.0

1272

11686

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

7.9

118

654

S10

ICPC

Boil/carbuncle

2.2

7.8

369

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

3.7

7.8

J01FA01

ATC

erythromycin; systemic

1.6

7.8

226

1520

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

7.7

138

807

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

7.7

376

XG410

NOMESCO Finland

Flow-volume spirometry

2.5

7.7

250

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

6.4

7.7

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

7.7

124

704

SPAT1059

SPAT

Spirometry at the office

2.3

7.7

323

XCH00

NOMESCO Finland

Eye pressure measurement

2.7

7.7

190

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.5

7.6

234

M01AB05

ATC

diclofenac; systemic, rectal

1.3

7.6

876

7591

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

7.6

394

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.7

7.6

142

844

M01AC06

ATC

meloxicam; systemic, rectal

1.4

7.6

440

3411

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

7.6

117

654

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

5.2

7.6

K02.1

ICD-10 Finland

Caries of dentine

1.3

7.6

877

7605

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

7.5

564

4569

L50.0

ICD-10 Finland

Allergic urticaria

2.9

7.5

157

M01AE02

ATC

naproxen; oral, rectal

1.3

7.5

831

7153

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

7.4

459

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

7.4

242

1669

C10AA05

ATC

atorvastatin; oral

1.4

7.4

354

2646

D06BX01

ATC

metronidazole; topical

1.7

7.3

138

822

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

7.3

217

1465

J01MA02

ATC

ciprofloxacin; systemic

1.4

7.3

453

3548

M54.2

ICD-10 Finland

Cervicalgia

1.9

7.3

509

EMB10

NOMESCO Finland

Tonsillectomy

1.9

7.2

109

605

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

7.2

125

725

CHD15

NOMESCO Finland

Trabeculectomy and iridectomy

15.8

7.2

H11.3

ICD-10 Finland

Conjunctival haemorrhage

3.2

7.2

110

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

5.8

7.2

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

7.2

340

2537

K08.80

ICD-10 Finland

Toothache NOS

1.8

7.2

116

661

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

7.2

133

788

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.2

7.2

336

SPAT1301

SPAT

No procedures

1.4

7.1

434

3383

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.4

7.1

253

P01AB01

ATC

metronidazole; oral, rectal

1.4

7.1

538

4352

R03CC02

ATC

salbutamol; systemic

1.7

7.1

141

855

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

7.1

144

878

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

7.1

134

800

D07AC14

ATC

methylprednisolone aceponate; topical

2.3

7.0

288

H15.0

ICD-10 Finland

Scleritis

10.1

7.0

F73

ICPC

Eye infection/inflammation other

3.2

7.0

107

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.6

7.0

193

V01AA05

ATC

tree pollen; parenteral

7.0

UJF32

NOMESCO Finland

Coloscopy

1.5

7.0

287

2078

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

7.0

539

SPAT1153

SPAT

Removal of sutures

1.4

7.0

378

2889

49300

ICD-8 Finland

Asthma, bronchiale

3.2

6.9

109

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

6.9

187

1235

S01FA04

ATC

cyclopentolate; ophthalmic

4.8

6.8

SPAT1131

SPAT

Colonoscopy

2.6

6.8

173

S01EB01

ATC

pilocarpine; ophthalmic

9.4

6.8

P06

ICPC

Sleep disturbance

1.7

6.8

143

883

J30.1

ICD-10 Finland

Allergic rhinitis due to pollen

40.2

6.8

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

6.7

110

627

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

3.5

6.7

SPAT1359

SPAT

Use of symptom diary

3.0

6.7

117

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

6.7

353

J20

ICD-10 Finland

Acute bronchitis

1.7

6.7

124

739

J35.0

ICD-10 Finland

Chronic tonsillitis

1.9

6.7

504

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

6.7

851

7423

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

6.6

148

928

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

6.6

540

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

5.5

6.6

R03AK08

ATC

formoterol and beclometasone; inhalant

2.4

6.6

226

L20.8

ICD-10 Finland

Other atopic dermatitis

4.6

6.6

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.7

6.6

164

R13

ICD-10 Finland

Dysphagia

2.1

6.6

348

K30

ICD-10 Finland

Functional dyspepsia

1.7

6.6

138

853

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

6.6

112

647

H03.1*B00.5

ICD-10 Finland

Herpesviral dermatitis of eyelid

10.1

6.5

H16.1

ICD-10 Finland

Other superficial keratitis without conjunctivitis

6.9

6.5

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

6.5

558

4587

A07AA02

ATC

nystatin; oral

2.0

6.5

365

K07.60

ICD-10 Finland

Snapping jaw

1.9

6.5

448

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

6.5

104

590

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

6.5

519

4224

R52.2

ICD-10 Finland

Other chronic pain

2.5

6.4

185

SPAT1009

SPAT

Measurement of intraocular pressure

4.1

6.4

J01MA14

ATC

moxifloxacin; systemic

1.8

6.4

549

N17

ICPC

Vertigo/dizziness

1.7

6.4

134

826

S05.0

ICD-10 Finland

Injury of conjunctiva and corneal abrasion without mention of foreign body

3.2

6.4

J01MA12

ATC

levofloxacin; systemic

1.5

6.3

196

1333

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

6.3

198

ZXA00

NOMESCO Finland

Right side

1.4

6.3

293

2169

H20

ICD-10 Finland

Iridocyclitis

8.2

6.3

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

6.3

792

6868

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

6.3

117

695

A03

ICPC

Fever

1.5

6.3

264

1918

M02AA07

ATC

piroxicam; topical

1.4

6.3

401

3143

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

18.1

6.3

H02.3

ICD-10 Finland

Blepharochalasis

2.1

6.2

334

HMAK

NOMESCO Finland

1.6

6.2

170

1127

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

6.2

472

B00.10

ICD-10 Finland

Herpes simplex facialis

5.0

6.2

V01AA02

ATC

grass pollen; systemic

7.7

6.1

N03AX09

ATC

lamotrigine; oral

2.0

6.1

393

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

6.1

316

D11

ICPC

Diarrhoea

1.6

6.1

176

1180

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

6.1

515

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

6.0

177

1192

S21

ICPC

Skin texture symptom/complaint

1.6

6.0

150

970

H53.2

ICD-10 Finland

Diplopia

2.7

6.0

138

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013707) Erythrocyte sedimentation rate by Westergren method

1283

10467

1.80

26.59

4.9

3.8

mm/h

11.1

10.6

0.57

1213

9722

(3005322) IgE [Units/volume] in Serum or Plasma

219

1021

2.30

26.43

1.5

1.2

u/ml

948.2

195.5

0.96

203

943

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

112

395

2.96

23.87

1.2

1.1

u/ml

3.8

2.3

0.40

174

(3013115) Eosinophils [#/volume] in Blood

974

7491

1.66

23.75

7.0

6.1

e9/l

0.2

5.81

886

6626

(3010726) Horse dander IgE Ab [Units/volume] in Serum

101

342

3.07

23.11

1.1

u/ml

3.8

2.3

0.46

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

837

6294

1.62

21.55

6.9

6.3

mmol/l

1.2

0.02

718

5345

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1257

10469

1.67

21.17

7.7

6.8

u/l

75.0

77.7

2.15

1191

9873

(3006315) Basophils [#/volume] in Blood

935

7244

1.61

21.11

6.9

5.9

e9/l

0.0

1.48

846

6320

(3003888) Timothy IgE Ab [Units/volume] in Serum

100

356

2.92

20.96

1.2

1.1

u/ml

7.2

6.8

0.08

196

(3001604) Monocytes [#/volume] in Blood

930

7217

1.60

20.70

6.9

5.8

e9/l

0.6

0.68

839

6293

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

599

4182

1.65

20.56

2.8

2.5

u/l

55.9

56.5

0.14

551

3874

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

890

6858

1.59

20.23

5.5

5.7

umol/l

11.5

10.8

0.44

840

6473

(3019198) Lymphocytes [#/volume] in Blood

949

7479

1.57

19.17

6.9

5.9

e9/l

2.0

0.10

870

6645

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

389

2460

1.74

19.14

1.3

1.2

u/ml

10.4

0.00

171

999

(3008401) Mugwort IgE Ab [Units/volume] in Serum

342

2.85

18.94

1.1

u/ml

1.3

1.6

0.12

159

(3014133) Dog dander IgE Ab [Units/volume] in Serum

268

3.08

18.67

1.1

u/ml

7.5

4.8

0.49

106

(3013650) Neutrophils [#/volume] in Blood by Automated count

1035

8369

1.56

18.29

9.2

8.7

e9/l

3.9

4.0

0.31

932

7340

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1630

14829

2.10

18.27

15.4

11.4

mg/l

19.6

21.0

1.12

1336

11376

(3023430) Cat dander IgE Ab [Units/volume] in Serum

242

3.15

17.99

1.1

u/ml

7.5

6.1

0.27

101

(3007853) Bacteria identified in Skin by Aerobe culture

269

1566

1.84

17.37

1.7

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

768

5870

1.54

17.10

2.4

2.3

nmol/l

75.0

74.8

0.07

702

5386

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

744

5672

1.53

16.62

6.1

5.7

mmol/l

1.2

0.43

682

5162

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

533

3806

1.57

15.82

1.4

1.3

u/ml

1.3

1.6

0.39

168

1010

(3037467) Urinalysis macro (dipstick) panel - Urine

1169

9869

1.53

15.77

4.9

4.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1514

13623

1.72

15.16

5.8

4.6

mu/l

1.8

2.1

0.83

1412

12711

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1343

11734

1.58

15.12

4.9

4.0

pmol/l

14.7

14.6

0.52

1241

10821

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

386

2586

1.63

14.85

1.3

iu/ml

29.8

30.0

0.01

110

795

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

604

4531

1.50

13.92

3.6

3.1

ng/l

41.8

41.9

0.00

351

2654

(3015171) Extractable nuclear Ab [Units/volume] in Serum

122

581

2.18

13.85

1.2

u/ml

0.6

1.3

0.62

(3022096) Basophils/100 leukocytes in Blood

821

6572

1.46

13.52

7.0

6.0

0.7

1.83

774

6165

(3012494) Peanut IgE Ab [Units/volume] in Serum

4.75

13.31

1.1

u/ml

6.3

15.5

0.33

(3007164) IgA [Mass/volume] in Serum or Plasma

451

3214

1.54

13.10

1.4

1.5

g/l

2.2

0.05

289

1984

(3013826) Glucose [Moles/volume] in Serum or Plasma

945

7803

1.45

13.01

4.9

4.4

mmol/l

6.5

0.13

885

7171

(3019069) Monocytes/100 leukocytes in Blood

845

6839

1.45

12.92

7.5

6.2

8.4

8.3

0.90

804

6450

(3006504) Eosinophils/100 leukocytes in Blood

840

6795

1.44

12.86

7.1

5.9

3.2

2.8

4.44

795

6362

(40760892) CBC W Ordered Manual Differential panel - Blood

482

3499

1.52

12.80

5.3

4.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

497

3635

1.51

12.73

2.2

2.1

u/l

168.5

231.1

0.90

477

3436

(3019550) Sodium [Moles/volume] in Serum or Plasma

1583

14576

1.74

12.62

15.6

12.4

mmol/l

139.7

139.6

0.68

1541

14170

(3002030) Lymphocytes/100 leukocytes in Blood

870

7099

1.44

12.62

7.1

5.9

29.6

29.5

0.08

821

6674

(3025159) Blasts/100 leukocytes in Blood

185

1059

1.83

12.46

4.8

4.3

1.3

0.7

0.16

238

(3008898) HLA-B27 [Presence]

126

634

2.06

12.41

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

194

1129

1.81

12.38

4.8

4.2

0.2

0.1

0.12

286

(3002179) Metamyelocytes/100 leukocytes in Blood

188

1085

1.82

12.33

4.4

4.0

0.4

0.5

0.17

223

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

7.79

12.29

1.0

u/ml

0.1

15.0

—

(3017181) Myelocytes/100 leukocytes in Blood

200

1178

1.79

12.26

4.7

4.2

0.6

0.9

1.35

312

(3037522) Nuclear Ab [Titer] in Serum

308

2038

1.62

12.25

1.4

1.3

titre

404.1

503.8

0.54

402

(3018010) Neutrophils/100 leukocytes in Blood

856

6993

1.43

12.18

6.8

5.7

55.6

56.1

0.74

813

6596

(3023103) Potassium [Moles/volume] in Serum or Plasma

1585

14629

1.73

12.14

15.7

12.5

mmol/l

3.9

1.56

1540

14197

(3021589) Normoblasts [#/volume] in Blood

809

6546

1.43

12.11

10.2

8.5

e9/l

0.0

0.22

689

5376

(3048689) Calprotectin [Mass/mass] in Stool

312

2082

1.60

11.97

2.6

2.4

ug/g

138.4

118.7

0.37

236

1642

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

6.98

11.86

1.1

1.0

u/ml

8.3

1.0

0.66

(3018418) pH of Serum or Plasma

497

3683

1.48

11.78

3.6

7.4

0.38

107

729

(3031040) Bacteria [#/volume] in Urine by Automated count

1088

9312

1.43

11.75

4.9

4.0

e6/l

7657.5

2665.4

0.48

118

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

223

2.75

11.70

1.0

u/ml

0.5

0.3

0.31

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

700

5544

1.43

11.66

4.0

3.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

7.14

11.43

1.0

u/ml

0.0

0.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

437

3172

1.50

11.42

2.6

2.4

umol/l

3099.6

4642.1

0.41

386

2796

(3024561) Albumin [Mass/volume] in Serum or Plasma

676

5346

1.42

11.25

5.3

4.7

g/l

36.3

0.05

626

4999

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1653

15502

1.86

11.18

16.4

12.7

umol/l

73.2

71.3

1.48

1653

15496

(40761511) CBC panel - Blood by Automated count

1662

15628

1.88

10.93

13.5

10.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

3.67

10.81

1.5

33.4

36.3

0.13

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1656

15598

1.82

10.19

11.3

9.0

u/l

26.2

25.9

0.37

1616

15095

(3023368) Bacteria identified in Blood by Culture

422

3106

1.47

10.13

3.8

—

(42870588) Differential panel, method unspecified - Blood

599

4704

1.41

10.11

6.9

5.9

—

(3035350) Ketones [Presence] in Urine by Test strip

851

7091

1.38

10.07

3.9

3.4

estimate

0.0

0.41

182

1371

(3029937) Albumin [Presence] in Urine by Test strip

502

3826

1.43

10.00

4.3

3.6

estimate

0.0

1.34

186

1373

(3036481) Cortisol [Moles/volume] in Serum or Plasma

216

1374

1.65

9.97

2.3

2.0

nmol/l

366.0

380.2

0.51

202

1273

(40768443) Skin Pathology biopsy report

486

2.05

9.70

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

857

7182

1.37

9.63

4.0

3.4

estimate

0.0

0.80

174

1368

(3034891) Synovial lining cells/100 cells in Synovial fluid

4.33

9.59

1.4

1.5

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

420

3122

1.45

9.50

2.2

1.8

mg/l

0.8

1.0

1.22

311

2302

(3021601) Nitrite [Presence] in Urine by Test strip

849

7119

1.37

9.44

5.2

4.6

estimate

0.0

0.50

184

1402

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

163

976

1.74

9.41

3.3

3.2

pmol/l

4.6

0.04

144

865

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

274

1880

1.54

9.16

2.0

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1281

11498

1.40

9.15

3.8

3.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

143

2.91

9.04

1.7

1.6

53.2

59.0

0.35

(40768797) Stomach Pathology biopsy report

261

1777

1.55

9.03

1.3

1.2

—

(3032080) INR in Blood by Coagulation assay

589

4683

1.38

9.01

7.8

7.1

inr

1.2

0.24

191

1485

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

358

2631

1.45

8.51

1.6

pmol/l

54333768.2

26048602.2

0.22

300

2242

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

6.88

8.45

1.1

1.0

—

(3026008) Bacteria identified in Urine by Culture

514

4044

1.38

8.25

3.1

2.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

493

3864

1.38

8.07

1.8

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

823

6983

1.33

7.97

3.3

2.7

ug/l

93.7

91.1

0.17

779

6527

(3015076) Soybean IgE Ab [Units/volume] in Serum

3.17

7.97

1.1

1.0

u/ml

0.5

5.7

0.45

(3025941) Bacteria identified in Stool by Culture

142

865

1.70

7.72

1.4

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

112

2.98

7.67

1.3

1.1

u/ml

25.6

1.5

1.01

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

586

4754

1.35

7.61

3.1

3.2

u/l

29.8

30.8

0.32

550

4534

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1461

13561

1.42

7.48

4.5

3.9

mmol/l

5.8

0.87

1355

12534

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

603

4933

1.34

7.35

1.9

1.8

pmol/l

101.1

97.1

1.07

304

2585

(3000850) Epithelial cells [#/volume] in Urine

354

2665

1.41

7.27

2.7

2.5

e6/l

6.1

7.7

1.21

312

2362

(3002582) Erythrocytes [#/volume] in Urine

488

3879

1.35

7.18

3.3

3.0

e6/l

67.6

64.3

0.04

380

2963

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

161

1039

1.60

7.00

2.9

3.3

mmol/l

1.2

0.11

144

902

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

430

3365

1.37

6.96

2.3

2.1

mg/l

2.8

2.9

0.18

380

2889

(3018095) Leukocytes [#/volume] in Urine

577

4727

1.33

6.86

3.9

3.5

e6/l

55.4

78.9

0.43

419

3209

(3007461) Platelets [#/volume] in Blood

1737

16817

2.09

6.86

21.9

16.8

e9/l

262.6

259.4

1.21

1710

16415

(3019309) Folate [Moles/volume] in Red Blood Cells

278

2029

1.44

6.76

1.7

nmol/l

1133.3

1205.0

0.74

221

1558

(3030467) Casts [#/volume] in Urine by Automated count

446

3526

1.35

6.73

3.2

3.0

e6/l

0.4

0.17

342

2645

(3014599) Egg white IgE Ab [Units/volume] in Serum

116

2.79

6.65

1.2

1.1

u/ml

34.2

1.9

0.52

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1125

10107

1.30

6.65

3.3

2.9

u/l

40.3

40.6

0.06

1063

9574

(3013139) Helicobacter pylori Ag [Presence] in Stool

146

932

1.62

6.64

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1444

13448

1.38

6.64

12.9

10.1

ml/min/173m2

88.9

88.6

0.18

1224

10857

(3024731) MCV [Entitic volume]

1737

16832

2.06

6.60

21.9

16.8

90.2

90.1

0.35

1719

16630

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1514

14221

1.42

6.54

4.8

4.2

mmol/l

2.8

0.47

1426

13298

(3026361) Erythrocytes [#/volume] in Blood

1737

16836

2.05

6.53

22.0

16.8

e12/l

4.5

1.25

1704

16414

(3000494) Fungus identified in Specimen by Culture

223

1573

1.48

6.47

1.5

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

297

2213

1.41

6.42

4.0

3.3

ng/l

112.2

531.5

4.50

200

1460

(4034850)

443

1.87

6.38

7.3

9.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

1737

16847

2.03

6.34

22.1

16.9

g/l

136.2

135.5

1.50

1720

16641

(3026782) Osmolality of Urine

330

2511

1.39

6.30

2.9

2.7

mosm/kgh2o

547.7

544.9

0.07

284

2167

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1497

14057

1.40

6.28

4.5

3.9

mmol/l

4.7

1.26

1418

13232

(3035941) MCH [Entitic mass]

1735

16833

1.98

6.13

21.9

16.7

30.1

0.22

1718

16630

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1489

13983

1.38

6.12

4.4

3.8

mmol/l

1.5

2.73

1401

13103

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

184

1265

1.51

6.05

1.9

1.7

—

(3010813) Leukocytes [#/volume] in Blood

1735

16839

1.97

6.03

22.0

16.9

e9/l

6.8

6.7

1.15

1701

16412

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

3.18

6.02

1.2

2.7

ug/l

22.9

127.1

0.48

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

475

1.81

5.97

1.7

1.6

iu/ml

0.6

0.2

0.31

(36304419) Bacteria [Presence] in Urine

437

3505

1.33

5.89

3.0

2.9

—

(3044889) 12 lead EKG panel

1035

9275

1.27

5.85

3.8

3.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

141

922

1.57

5.82

4.2

4.1

ng/l

76.5

75.9

0.03

125

829

(3042936) Bacteria identified in Isolate by Culture

245

1799

1.42

5.73

2.0

1.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

496

4066

1.30

5.68

3.5

3.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1343

12461

1.31

5.67

5.7

4.8

mmol/mol

39.3

38.7

1.56

1254

11697

(40758558) Short blood count panel - Blood

448

3623

1.32

5.67

7.0

6.3

—

(3009508) Creatinine [Moles/volume] in Urine

481

3933

1.30

5.60

3.5

3.3

mmol/l

8.0

7.7

0.58

421

3400

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

363

2853

1.34

5.59

2.6

2.9

ng/l

1742.9

922.3

0.81

293

2349

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

485

1.77

5.59

1.4

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

406

1.83

5.50

1.8

1.7

g/l

0.2

0.35

383

(3003327) Ova and parasites identified in Stool by Light microscopy

526

1.73

5.47

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

183

1284

1.47

5.45

2.0

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

150

1010

1.53

5.45

5.7

8.5

g/l

126.5

122.3

1.69

145

978

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

276

2089

1.38

5.40

2.6

e6/l

1.2

1.1

0.13

158

1151

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

176

1234

1.47

5.27

5.4

7.8

kpa

5.1

0.16

171

1182

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

169

2.28

5.25

1.6

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

428

1.79

5.21

1.7

g/l

1.2

0.49

401

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1430

13434

1.32

5.18

4.0

3.5

mmol/l

1.3

2.09

1336

12544

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

459

1.75

5.17

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

103

2.65

5.16

1.3

u/ml

0.1

1.0

0.91

(3027801) Oxygen [Partial pressure] in Arterial blood

175

1234

1.46

5.09

5.4

7.7

kpa

12.5

13.0

0.51

170

1183

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.30

5.03

1.4

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

143

972

1.51

4.99

2.5

2.3

au/ml

7.4

21.1

3.32

(3019150) Specific gravity of Urine by Refractometry

392

3162

1.31

4.98

4.0

3.6

kg/l

1.0

1.35

472

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

247

2.01

4.96

1.4

1.8

g/l

0.0

0.00

231

(3012516) Albumin [Mass/volume] in Urine

405

3284

1.30

4.95

3.5

3.3

mg/l

196.1

327.2

0.38

262

2096

(3008152) Bicarbonate [Moles/volume] in Arterial blood

104

659

1.61

4.93

7.1

7.5

mmol/l

24.8

24.5

0.45

619

(3015377) Calcium [Moles/volume] in Serum or Plasma

519

4349

1.27

4.89

3.3

3.2

mmol/l

2.3

2.4

3.16

460

3893

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

249

2.00

4.86

1.4

1.8

g/l

0.0

0.00

232

(3020682) Albumin/Creatinine [Ratio] in Urine

423

3459

1.29

4.84

4.1

mg/mmol

12.0

8.3

0.48

274

2210

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

292

1.91

4.82

1.1

1.4

—

(3003396) Base excess in Arterial blood by calculation

172

1223

1.45

4.80

5.4

7.8

mmol/l

1.4

0.9

0.83

136

957

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

178

1274

1.44

4.80

1.2

iu/ml

113.6

134.5

0.40

494

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

3.43

4.75

1.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

118

778

1.55

4.74

3.0

2.8

ng/l

157.8

161.7

0.04

103

702

(3021960) Folate [Moles/volume] in Serum or Plasma

341

2717

1.32

4.72

1.6

1.5

nmol/l

20.1

20.6

0.24

305

2351

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

427

1.74

4.69

3.0

5.9

1.8

1.6

0.61

400

(44813793)

121

2.42

4.65

1.2

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

305

1.86

4.56

1.6

2.0

g/l

0.3

0.7

0.61

272

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

401

1.75

4.55

1.6

1.9

iu/l

3.4

5.3

0.86

149

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

270

1.91

4.52

1.5

1.8

g/l

0.0

0.50

253

(3007930) Methemoglobin/Hemoglobin.total in Blood

425

1.72

4.50

2.8

5.9

0.9

0.61

396

(3019060) Gas panel - Arterial blood

106

691

1.57

4.49

4.1

5.3

—

(3002385) Erythrocyte distribution width [Ratio]

1364

12806

1.27

4.49

17.3

13.9

13.4

13.5

1.00

1342

12531

(3017446) Testosterone [Moles/volume] in Serum or Plasma

124

838

1.52

4.47

2.4

2.2

nmol/l

13.0

12.3

0.37

113

755

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

487

1.67

4.47

4.5

3.6

48.0

50.0

0.27

478

(3020630) Protein [Mass/volume] in Serum or Plasma

124

841

1.51

4.40

2.1

2.6

g/l

66.9

67.1

0.09

113

782

(4010399)

129

884

1.49

4.36

1.5

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

255

1975

1.34

4.29

2.8

2.7

e6/l

4.0

3.5

0.18

140

1042

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

276

1.87

4.25

1.4

1.7

g/l

38.3

38.1

0.08

243

(3022948) Iron [Moles/volume] in Serum or Plasma

250

1943

1.33

4.11

2.6

2.3

umol/l

13.0

14.0

1.32

238

1789

(3028433) Virus identified in Specimen by Culture

3.53

4.05

1.2

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

390

3222

1.27

4.04

3.9

3.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

125

865

1.48

4.04

1.6

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

419

3503

1.26

3.92

1.8

1.6

mmol/l

1.4

0.21

358

3018

(3000492) Spirometry study

190

1428

1.37

3.89

1.5

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

546

1.58

3.87

2.0

2.2

u/l

41.4

39.8

0.35

498

(3018405) Lactate [Moles/volume] in Arterial blood

399

1.68

3.83

4.5

3.8

mmol/l

1.3

1.4

0.52

391

(3022145) Colonoscopy Study observation

194

1469

1.36

3.79

1.4

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

369

3052

1.26

3.77

2.4

2.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

101

679

1.52

3.77

1.9

2.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

108

2.33

3.76

1.4

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

340

1.73

3.76

1.4

1.9

g/l

3.0

3.1

0.20

268

(3009445) Proteinase 3 Ab [Units/volume] in Serum

520

1.58

3.71

1.3

1.7

—

10.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

109

2.31

3.69

1.4

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

197

1.95

3.64

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

338

2779

1.27

3.63

2.3

2.2

—

(40761535) Cells panel - Urine sediment

140

1012

1.42

3.62

4.4

3.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

163

2.04

3.61

1.2

1.3

nmol/l

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

301

1.75

3.54

1.8

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

193

1477

1.34

3.53

1.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

225

1765

1.31

3.47

2.6

2.3

g/l

2.5

2.4

0.86

211

1629

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

587

1.52

3.43

2.4

2.3

—

(36660697) Celiac disease serology panel - Serum

175

1327

1.35

3.41

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

305

1.73

3.40

2.1

2.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

134

973

1.41

3.39

5.4

4.2

kpa

4.5

4.7

0.34

129

936

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

268

2160

1.28

3.38

3.1

2.7

mmol/l

2.4

0.99

240

1917

(3003458) Phosphate [Moles/volume] in Serum or Plasma

212

1656

1.32

3.37

6.4

5.7

mmol/l

1.1

0.48

197

1552

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

359

1.67

3.37

1.4

1.9

g/l

3.7

3.8

0.01

259

(3017143) Hepatitis C virus Ab [Presence] in Serum

262

2106

1.29

3.37

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

360

1.66

3.34

1.4

1.9

g/l

7.3

7.5

0.49

276

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

360

1.66

3.34

1.4

1.9

—

(3022217) INR in Platelet poor plasma by Coagulation assay

167

1268

1.35

3.23

16.5

19.0

inr

1.1

1.2

0.91

199

(3012095) Magnesium [Moles/volume] in Serum or Plasma

248

1991

1.29

3.22

3.4

3.8

mmol/l

0.8

0.81

235

1867

(3002032) Base excess in Venous blood by calculation

152

1141

1.36

3.17

6.1

4.4

mmol/l

2.0

1.8

0.22

122

908

(3020891) Body temperature

445

1.57

3.15

6.1

4.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

237

1.79

3.15

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

237

1.79

3.15

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

462

1.56

3.12

2.1

1.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

284

1.71

3.07

1.2

1.1

au/ml

4.1

12.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

330

1.66

3.07

1.5

1.9

g/l

10.0

10.4

0.46

286

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

228

1829

1.28

2.99

2.1

2.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

183

1.87

2.97

1.1

1.3

nmol/l

—

0.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

326

1.64

2.95

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

303

1.67

2.94

3.3

3.7

56.8

0.00

303

(3030905) Polymorphonuclear cells [#/volume] in Blood

296

1.67

2.92

3.1

3.4

e9/l

4.1

0.10

296

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

267

1.70

2.87

1.2

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

6.68

2.87

1.0

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.94

2.86

3.2

2.0

umol/l

16.0

15.6

0.03

(3000991) Gas panel - Venous blood

137

1030

1.36

2.85

7.5

8.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.30

2.84

1.0

1.1

miu/ml

1478.9

1641.3

0.27

(3008037) Lactate [Moles/volume] in Venous blood

238

1.74

2.82

3.0

2.7

mmol/l

1.5

0.05

231

(3047181) Lactate [Moles/volume] in Blood

347

1.60

2.78

4.1

7.0

mmol/l

1.0

1.3

1.95

296

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

203

1620

1.29

2.78

2.8

2.3

21.9

23.6

1.01

178

1390

(3033658) Prothrombin time (PT) actual/Normal

387

3319

1.21

2.78

4.1

3.8

94.4

93.4

0.35

381

3230

(3005719) IgG [Mass/volume] in Serum or Plasma

139

1055

1.34

2.73

2.8

g/l

10.5

10.3

0.21

129

959

(3015183) Erythrocyte sedimentation rate

2.16

2.71

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

265

2191

1.25

2.70

1.7

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.51

2.70

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

6.02

2.70

7.5

2.3

—

(40768804) Tissue Pathology biopsy report

625

5611

1.17

2.67

2.1

2.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

169

1.85

2.63

1.1

1.4

—

(3021788) Differential panel - Synovial fluid

206

1.76

2.62

1.8

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

346

1.58

2.58

2.0

2.3

mg/l

8.7

11.1

1.89

321

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

568

1.45

2.55

6.8

10.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

120

1576

0.74

2.53

1.7

1.6

—

(3039000) Anion gap in Blood

225

1.70

2.48

3.3

8.8

mmol/l

11.1

11.3

0.19

202

(3018572) Chloride [Moles/volume] in Blood

226

1.70

2.44

3.3

8.8

mmol/l

104.8

105.5

0.43

203

(3010144) Erythrocytes [#/volume] in Synovial fluid

110

2.01

2.41

1.6

1.2

e6/l

246987.4

108966.4

0.23

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

243

1.66

2.38

2.6

2.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

134

1036

1.32

2.35

10.9

7.6

mmol/l

8.5

8.0

0.47

127

990

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

678

0.64

2.28

1.4

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

382

1.51

2.27

1.6

1.4

ug/g

291.0

301.7

0.15

217

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

160

1274

1.28

2.26

5.1

4.1

u/l

243.1

245.5

0.06

148

1209

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

120

1.93

2.26

1.2

1.1

—

(4094501)

303

1.57

2.23

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

210

1731

1.24

2.22

1.6

1.8

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.57

2.21

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.57

2.21

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.51

2.18

1.6

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

259

1.60

2.13

1.3

1.2

—

(3013512) EKG study

394

3466

1.18

2.11

4.1

3.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.71

2.10

1.1

1.2

pmol/l

220.5

319.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

260

1.59

2.10

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.57

2.09

1.2

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

284

1.56

2.09

6.8

6.6

iu/ml

151.8

331.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.14

2.08

2.5

3.7

mg/l

8.0

8.3

0.06

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

310

1.53

2.04

1.2

u/ml

5.0

38.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

108

831

1.32

2.00

1.7

1.8

g/l

1.2

1.4

0.63

102

765

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

725

6691

1.14

2.00

4.0

3.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

249

1.58

1.96

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

558

0.64

1.95

1.3

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

135

1.79

1.91

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.93

1.90

1.1

1.2

ratio

1.1

1.0

—

(4062490)

143

1.76

1.89

1.3

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

300

1.51

1.88

1.4

u/l

21.2

22.7

0.12

255

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.16

1.88

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

433

1.42

1.87

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1116

0.75

1.85

1.5

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

359

1.46

1.85

1.9

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

167

1.69

1.84

1.3

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.54

1.84

1.0

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

181

1502

1.23

1.83

7.1

6.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

116

1.82

1.78

1.4

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

715

1.32

1.76

1.9

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

102

1.87

1.76

1.4

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.94

1.75

1.4

2.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.51

1.74

1.2

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.85

1.71

1.8

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

3.85

1.71

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

226

1.56

1.71

1.6

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

374

1.43

1.70

1.3

u/ml

3.8

11.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

132

1068

1.25

1.69

3.6

4.1

ug/l

19.7

19.4

0.01

102

842

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

252

1.52

1.66

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

367

3272

1.15

1.64

2.4

2.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

127

1027

1.25

1.64

5.8

7.3

mmol/l

1.3

0.30

120

977

(3000475) Leukocytes [#/volume] in Synovial fluid

269

1.50

1.64

2.0

1.6

e6/l

12337.1

12116.8

0.01

203

(3047352) Trisomy 18 risk [Likelihood] in Fetus

520

0.67

1.60

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

124

1004

1.25

1.60

2.3

2.4

ml/min/173m2

69.4

72.9

0.46

399

(3014765) Yersinia sp identified in Stool by Organism specific culture

440

1.38

1.57

1.2

—

(3005033) Fetal Nuchal fold Thickness US

517

0.67

1.56

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

694

1.30

1.55

1.3

—

(3009343) pH of Capillary blood

103

819

1.27

1.55

5.1

4.3

7.4

0.77

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

122

1.73

1.54

1.7

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

695

1.30

1.54

2.0

1.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

151

1255

1.22

1.54

3.7

3.1

1.7

1.8

0.46

132

1134

(3010838) Calcium [Moles/time] in 24 hour Urine

1.98

1.54

1.1

1.5

—

11.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

537

1.34

1.54

4.1

3.4

1.3

0.16

531

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

104

829

1.27

1.53

5.1

4.3

kpa

5.1

0.17

781

(3024869) Neuronal Ab [Presence] in Serum

3.34

1.52

1.2

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

152

1267

1.22

1.51

3.9

2.8

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.86

1.50

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

367

1.40

1.50

1.3

u/ml

6.7

2.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

100

796

1.27

1.50

5.1

4.3

mmol/l

1.1

1.5

0.42

587

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

226

1.51

1.49

1.6

1.7

—

1428.6

—

(3000034) Microalbumin [Mass/volume] in Urine

101

1.79

1.49

2.3

3.2

mg/l

9.7

22.7

0.72

(3021879) Hepatitis B virus core Ab [Presence] in Serum

160

1343

1.21

1.48

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

576

1.32

1.47

6.1

9.7

mmol/l

24.8

24.3

0.99

541

(3012501) Base excess in Blood by calculation

268

1.47

2.1

3.5

mmol/l

1.9

2.5

0.82

165

(3043238) Trisomy 21 risk [Likelihood] in Fetus

533

0.69

1.47

1.4

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

163

1.60

1.46

1.2

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

455

1.35

1.46

2.4

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

447

1.35

1.45

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

404

1.37

1.45

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.98

1.43

1.2

—

72.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

221

1.50

1.41

1.2

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

118

1.70

1.41

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

238

1.48

1.40

2.1

2.4

17.0

16.6

0.26

119

(3004451) EKG impression Narrative

2.18

1.40

1.9

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

2.18

1.40

1.4

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

138

0.43

1.40

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

724

1.27

1.39

1.8

—

(3037121) Protein [Mass/volume] in Urine

478

1.33

1.36

5.5

4.0

g/l

0.6

0.3

0.50

212

(3009542) Hematocrit [Volume Fraction] of Blood

1459

14226

1.14

1.35

14.7

12.1

40.3

40.0

0.97

1101

11081

(3019225) pH of Specimen

144

1210

1.21

1.34

5.7

3.8

—

(3044640) Blood type and Crossmatch panel - Blood

472

4335

1.12

1.33

2.5

2.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

128

1.65

1.33

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

1.92

1.33

1.2

—

1100.0

—

(3017732) Neutrophils [#/volume] in Blood

119

983

1.23

1.32

3.6

2.6

e9/l

4.4

4.1

0.76

823

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

113

1.69

1.32

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

113

1.69

1.32

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

113

1.69

1.32

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.74

1.31

2.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

209

1.49

1.30

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.50

1.30

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

2.10

1.30

1.2

1.0

u/ml

48.6

37.8

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

226

1.47

1.29

1.0

1.1

133.1

117.6

1.31

208

(3023520) Reticulocytes [#/volume] in Blood

109

895

1.23

1.28

3.3

2.9

e9/l

70.1

72.8

0.32

659

(3045683) HLA typing for celiac disease panel - Blood or Tissue

114

1.67

1.28

1.1

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

379

1.36

1.28

2.8

3.3

u/ml

1110.5

789.8

0.13

326

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

302

1.40

1.28

1.5

1.6

—

(3010421) pH of Blood

319

1.39

1.28

2.0

3.3

7.4

0.76

265

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

244

1.44

1.26

1.0

1.2

u/ml

1.3

3.9

1.59

(3021901) Oxygen saturation in Capillary blood

203

1.49

1.25

2.3

2.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

118

0.42

1.24

1.6

1.5

g/l

1.0

—

118

(4015189)

2.40

1.24

1.2

2.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

100

1.71

1.23

3.2

3.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

504

1.30

1.23

2.5

1.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

106

873

1.23

1.22

2.3

2.2

ug/l

7.3

6.9

0.06

100

768

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

674

1.26

1.22

7.7

5.2

mmol/l

24.4

24.0

0.50

617

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.17

1.21

1.3

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

146

1243

1.19

1.20

2.6

2.3

u/l

37.4

78.5

0.52

128

1042

(4146454)

101

1.69

1.20

2.9

2.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.84

1.19

1.0

1.1

105.8

92.2

1.75

(3016650) Hepatitis A virus Ab [Presence] in Serum

264

1.41

1.19

1.3

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

170

0.53

1.18

1.4

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

173

1.51

1.18

1.2

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

173

1.51

1.18

1.2

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

174

1.50

1.15

1.2

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.06

1.15

1.4

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.50

1.15

1.2

2.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

126

1.59

1.14

1.1

iu/ml

4.0

11.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

134

1.57

1.14

1.7

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

327

1.35

1.13

1.1

1.8

e6/l

46.7

20.3

0.26

250

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

327

1.35

1.13

1.1

1.9

e6/l

1437.1

1536.2

0.02

262

(3033799) Differential panel - Peritoneal fluid

2.34

1.12

2.0

1.8

—

(3036489) Thrombin time

548

1.27

1.11

3.1

2.6

21.0

21.2

0.27

481

(1002224) Polysomnography panel

611

1.25

1.11

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

650

0.76

1.10

1.4

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

650

0.76

1.10

1.4

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

650

0.76

1.10

1.4

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

729

1.23

1.10

1.3

miu/ml

188.1

222.9

0.48

364

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

113

1339

0.83

1.10

1.4

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.67

1.10

2.1

1.4

pmol/l

77.4

51.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

648

0.77

1.08

1.4

1.5

—

(3003181) Sodium [Moles/volume] in Urine

202

1.44

1.07

1.6

1.5

mmol/l

70.5

72.9

0.08

167

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

219

1.42

1.07

1.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

270

1.38

1.07

1.7

1.8

—

2.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

138

1184

1.18

1.06

2.3

2.4

g/l

0.2

0.05

125

1108

(3003338) MCHC [Mass/volume]

1360

13263

1.11

1.06

18.6

14.3

g/l

332.9

332.8

0.11

1352

13159

(3021387) Prolactin [Units/volume] in Serum or Plasma

816

1.21

1.05

1.7

1.6

mu/l

327.6

306.2

0.19

731

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

306

1.35

1.04

1.5

1.6

—

(1616796) Gas panel - Central venous blood

263

1.38

1.04

2.0

3.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

298

1.35

1.03

2.2

nmol/l

0.8

0.00

252

(3033705) Calcium.ionized [Moles/volume] in Venous blood

130

1.54

1.02

2.8

2.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

115

976

1.19

1.01

1.4

iu/l

28.1

24.7

0.42

808

(40768800) Prostate Pathology biopsy report

107

0.47

1.01

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.88

1.00

2.3

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

458

1.28

1.00

1.1

u/ml

1.0

5.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

300

1.34

0.99

4.9

3.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

576

1.24

0.98

1.5

u/l

12.6

9.6

0.62

462

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

625

0.78

0.96

2.1

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

678

1.22

0.96

1.4

1.7

mg/l

3.5

4.5

0.48

472

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

259

1.36

0.95

1.7

1.8

pmol/l

198.6

203.0

0.07

246

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.77

0.94

1.1

g/l

0.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

158

1.46

0.93

3.7

4.1

u/ml

26.5

125.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.23

0.93

1.5

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

120

0.50

0.93

1.8

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.15

0.91

1.2

3.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

160

1.44

0.89

1.7

1.4

pmol/l

286.3

338.6

0.59

125

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.69

0.89

1.8

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

246

1.35

0.87

1.1

1.2

u/ml

2.7

4.3

0.84

117

(3052851) Hemolysis interference index of Serum or Plasma

378

1.28

0.87

3.8

3.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

281

1.32

0.87

2.1

3.2

mg/l

37.9

40.7

0.08

219

(3034860) Kappa light chains.free [Mass/volume] in Serum

281

1.32

0.87

2.1

3.3

mg/l

57.9

62.8

0.07

220

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

725

0.81

0.87

1.4

1.5

—

(40768446) Kidney Pathology biopsy report

1.72

0.86

3.1

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

128

1.49

0.86

1.2

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

213

1.37

0.84

2.2

3.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.94

0.84

1.3

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

179

1.40

0.84

4.1

3.3

0.7

1.2

0.83

144

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

249

1.33

0.82

1.8

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

860

0.83

0.81

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

302

1.30

0.81

1.2

1.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.61

0.81

1.2

1.3

—

(3003694) ABO and Rh group [Type] in Blood

433

4611

0.92

0.81

1.5

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

155

1.42

0.81

1.7

1.5

—

(3023419) Bacteria identified in Sputum by Culture

130

1.47

0.81

2.1

3.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.79

0.0

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

456

1.24

0.79

2.0

1.9

g/l

1.4

1.5

0.20

408

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

173

1.39

0.79

1.1

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

173

1.39

0.79

1.1

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.63

0.78

4.5

3.4

umol/l

182.0

151.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.52

0.78

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

170

1523

1.13

0.77

3.0

2.9

umol/l

6.9

7.7

0.26

141

1290

(3005988) Vibrio sp identified in Specimen by Organism specific culture

174

1.38

0.77

1.1

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

323

1.28

0.76

2.3

2.6

umol/l

14.9

5.7

0.69

236

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.65

0.75

1.9

3.4

u/ml

497.9

848.8

0.91

(46235355) HIV 1 and 2 tests - Meaningful Use set

425

3996

1.08

0.75

1.9

2.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

121

1063

1.15

0.75

2.1

2.2

u/l

3674.6

6338.8

0.84

409

(3006184) Hemoglobin [Mass/volume] in Capillary blood

271

1.30

0.74

1.8

2.2

g/l

133.4

132.2

0.13

203

(3017509) Phencyclidine [Presence] in Urine

2.00

0.72

1.0

1.2

—

(3011412) CD3 cells [#/volume] in Blood

134

1.42

0.71

2.4

2.8

e9/l

1.3

1.2

0.22

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

109

1.47

0.71

1.1

—

290.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.93

0.70

1.6

2.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

212

1.33

0.70

1.3

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

629

1.18

0.70

2.0

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.55

0.69

3.4

4.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.53

0.69

5.5

6.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

342

3199

1.09

0.69

1.6

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

230

2499

0.91

0.68

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.64

0.68

1.7

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.64

0.68

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.64

0.68

1.7

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.64

0.68

1.7

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

205

1.32

0.67

1.6

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

294

1.26

0.66

3.8

3.7

u/ml

0.3

0.10

150

(3011648) Oxygen content in Venous blood

1.49

0.66

5.7

7.7

11.8

11.5

0.12

(44806118)

162

1.36

0.66

1.6

1.5

—

(44790049)

162

1.36

0.66

1.6

1.5

—

(44790047)

162

1.36

0.66

1.6

1.5

—

(44790048)

162

1.36

0.66

1.6

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

167

0.66

1.6

1.5

—

(4024509)

111

1.45

0.66

1.9

1.4

—

(40768795) Lymph node Pathology biopsy report

128

1.41

0.65

1.1

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.59

0.65

2.0

1.4

ug/l

14.4

8.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.50

0.63

1.2

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.64

0.62

1.5

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.64

0.62

1.5

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.64

0.62

1.5

1.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

325

1.24

0.61

1.7

1.4

nmol/l

0.3

0.07

255

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

191

1.31

0.61

1.2

u/l

42.2

28.3

0.31

167

(3024263) Appearance of Synovial fluid

1.57

0.60

3.7

1.8

—

(3034426) Prothrombin time (PT)

1.57

0.60

1.0

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.45

0.59

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.57

0.58

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.72

0.57

1.3

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.72

0.57

1.0

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.48

0.57

1.1

—

(3024471) HLA-A [Type]

1.48

0.57

1.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

107

1.41

0.55

2.8

2.5

11.3

12.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

179

1646

1.10

0.55

3.4

3.6

23.8

21.4

0.99

668

(3006653) Thiamine [Moles/volume] in Blood

1.50

0.54

1.1

1.4

nmol/l

134.0

146.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.50

0.54

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

525

1.17

0.54

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

108

1.39

0.53

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.54

0.53

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.54

0.53

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

336

3178

1.07

0.52

1.5

—

(3000330) Specific gravity of Urine by Test strip

639

1.15

0.52

4.4

3.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

100

1.40

0.52

1.3

1.1

—

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.50

0.51

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.50

0.51

2.8

2.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

281

0.78

0.51

4.5

3.2

mg/l

19.0

24.9

0.99

173

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

188

1.28

0.51

1.3

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

325

0.80

0.51

3.3

2.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

224

1.25

0.51

1.5

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

109

1.38

0.51

4.4

2.6

43.4

58.5

—

(3042631) Mycobacterium sp identified in Specimen

127

1.34

0.49

1.8

2.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

110

1.37

0.48

1.1

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

646

0.86

0.48

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

154

1.30

0.48

1.3

1.2

—

(4306422)

235

1.24

0.48

1.0

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

1.45

0.48

45.4

36.8

ug/l

7.1

7.2

0.10

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

223

2088

1.08

0.47

4.0

4.1

ug/l

1.4

2.0

2.10

202

1879

(3023420) DNA double strand Ab [Units/volume] in Serum

146

1.30

0.47

1.2

1.6

—

21.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

337

1.19

0.46

1.2

—

(3022313) Gas panel - Capillary blood

627

1.14

0.46

5.1

4.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

328

1.19

0.46

1.8

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.43

0.46

1.0

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.43

0.46

1.0

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

147

1.30

0.45

1.7

1.8

91.5

90.3

0.88

147

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

108

981

1.11

0.45

1.1

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.37

0.44

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

184

1.25

0.43

1.4

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

104

1.35

0.43

1.3

1.1

—

40.4

—

(3022689) Creatine [Moles/volume] in Urine

1.61

0.43

1.6

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.56

0.42

1.4

2.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

425

1.16

0.42

7.9

7.2

mg/l

1.4

1.3

0.22

399

(3044242) Glucose [Moles/volume] in Arterial blood

1.38

0.41

2.3

2.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.38

0.41

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

314

1.18

0.41

1.9

2.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.36

0.41

1.0

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.40

0.0

5.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

9.9

—

(3044007) Cell count panel - Peritoneal fluid

1.47

0.40

1.6

1.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.47

0.40

17.8

6.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.40

0.0

3.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.40

0.0

4.7

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.40

0.0

3.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.43

0.39

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.43

0.39

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.43

0.39

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.43

0.39

1.0

1.1

—

(3024928) Oxygen saturation in Venous blood

251

1.20

0.39

5.1

4.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

133

1.28

0.38

4.4

4.2

—

(3023410) Appearance of Cerebral spinal fluid

151

1.26

0.38

1.3

2.4

—

(40765096) Chromosome analysis panel by Banding

1.39

0.38

1.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

217

2051

1.07

0.37

1.7

1.8

1.5

1.4

0.97

192

1857

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.35

0.37

1.0

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

152

1.25

0.37

1.2

2.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

180

0.78

0.37

1.3

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.63

0.35

1.2

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.32

0.35

2.8

1.9

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

1.40

0.35

3.8

2.3

e6/l

21069.0

726.7

—

(4035726)

119

1104

1.08

0.34

1.6

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.36

0.34

1.3

2.5

—

63759.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.36

0.34

1.3

2.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.36

0.34

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

200

1.20

0.33

3.0

2.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

127

1.26

0.33

1.4

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

833

0.91

0.33

2.1

2.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

166

0.78

0.33

1.3

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.31

0.33

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.67

0.33

1.5

1.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

285

1.16

0.32

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

137

1.24

0.32

1.1

—

(3044941) Cell count panel - Synovial fluid

183

1.20

0.31

1.5

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

101

1.29

0.31

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

101

1.29

0.31

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

101

1.29

0.31

1.3

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

286

1.16

0.31

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

258

1.17

0.31

1.2

1.1

iu/ml

32.4

1736.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

109

1014

1.08

0.31

1.4

—

(3017569) Oxygen content in Arterial blood

1.32

0.30

1.1

2.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.32

0.30

1.6

1.1

—

(21494434) Karyotype in Bone marrow

100

0.70

0.30

1.0

1.2

—

(3024932) HLA-DR beta [Type]

1.30

0.30

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.30

0.30

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.27

0.30

1.0

1.1

—

16.8

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

102

1.28

0.30

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

102

1.28

0.30

1.3

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

102

1.28

0.30

2.1

2.4

e6/l

1753.6

762.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

102

1.28

0.30

1.3

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

166

1.21

0.30

1.2

1.1

—

(3045414) Leukocytes [Presence] in Urine

630

1.10

0.30

2.2

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

166

1575

1.06

0.28

4.4

3.8

32.7

32.1

0.30

117

1119

(3000012) Reticulocyte production index

1.29

0.28

1.8

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.29

0.28

1.0

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

855

1.08

0.28

2.3

3.1

u/ml

28.6

49.9

1.35

826

(4198724)

116

0.77

0.27

2.6

1.9

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

394

1.12

0.27

1.5

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

122

1.23

0.27

1.0

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

169

1.19

0.26

1.0

1.1

103.6

95.6

0.68

160

(4268621)

169

1.19

0.26

1.8

2.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

263

1.14

0.25

1.6

1.5

—

(3012565) Volume of 24 hour Urine

1.23

0.25

1.4

2.5

2445.9

2038.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.23

0.25

1.1

—

(3045788) Cell count panel - Pleural fluid

1.23

0.25

1.6

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

378

1.11

0.24

1.5

1.3

u/ml

297.8

228.6

1.15

220

(3035637) Corticotropin [Mass/volume] in Plasma

170

1.18

0.24

1.5

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.17

0.24

1.2

5.5

—

54.2

—

(3037756) Immunofixation for Serum or Plasma

208

1.16

0.24

1.1

1.7

—

(40768806) Pleura Pathology biopsy report

0.70

0.24

2.0

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

106

1.23

0.23

1.5

1.6

umol/l

11.9

10.5

0.45

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

136

0.81

0.23

2.3

1.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.25

0.22

1.2

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

593

1.08

0.22

1.6

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

710

0.93

0.22

1.5

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.22

0.22

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

107

1.22

0.21

3.0

2.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

107

1.22

0.21

1.2

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

7.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

10.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

1.6

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

182

1.16

0.21

1.5

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

156

0.83

0.21

2.0

2.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

344

1.11

0.21

2.2

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.16

0.21

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.16

0.21

1.2

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.16

0.21

1.0

3.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.21

0.0

2.0

—

(40761536) Microorganisms panel - Urine sediment

136

1299

1.05

0.20

4.1

3.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

0.00

0.20

0.0

1.0

—

2.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.20

0.0

1.1

—

30.3

—

(3026726) Creatinine [Moles/volume] in Specimen

0.00

0.20

0.0

3.4

—

284.2

—

(3042733) HLA Ab [Presence] in Serum

1.20

0.19

3.7

4.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.20

0.19

1.0

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

317

1.11

0.19

1.5

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.22

0.19

1.1

—

(3022621) pH of Urine by Test strip

920

1.06

0.19

3.2

2.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.24

0.18

1.1

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

100

1.20

0.18

1.3

2.1

—

1.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.17

0.17

2.7

3.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

163

0.86

0.17

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.11

0.17

1.6

1.9

—

(3020491) Glucose [Moles/volume] in Blood

111

1.17

0.15

2.1

1.7

mmol/l

6.1

6.5

—

(3012441) Differential panel - Pleural fluid

0.78

0.15

1.2

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

332

1.09

0.15

1.3

1.5

—

(4027681)

102

1.18

0.15

1.2

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

471

0.93

0.14

2.5

2.8

—

(3011288) Drugs identified in Urine by Screen method

734

1.05

0.14

2.5

3.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

0.82

0.13

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

149

0.87

0.13

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

159

0.88

0.13

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

113

1.15

0.13

1.8

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

248

1.09

0.12

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

123

1.14

0.12

2.6

1.8

—

(3002256) Pathology report gross observation

167

1716

0.97

0.12

1.3

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

342

0.93

0.10

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

146

0.89

0.10

2.3

2.2

mg/l

15.8

25.9

—

(1761868) Lipid panel - Serum or Plasma

552

5461

1.02

0.10

2.8

2.5

—

(3016879) Cocaine [Presence] in Urine

992

0.97

0.10

1.9

2.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.15

0.10

1.5

2.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

341

0.94

0.10

1.8

1.4

—

11.6

—

(3014271) Vancomycin [Susceptibility]

1.14

0.10

1.8

2.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.14

0.10

1.2

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

164

1.10

0.09

3.6

3.0

nmol/l

0.7

0.8

1.85

130

(3025577) Chromium [Mass/volume] in Blood

1.09

0.09

2.5

2.1

ug/l

3.4

2.2

—

(3017704) Immunofixation for Urine

1.05

0.08

1.0

1.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.05

0.08

1.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.82

0.08

2.8

3.0

ug/l

0.8

1.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.83

0.08

1.0

1.1

iu/ml

193.8

190.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.03

0.07

1.1

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.03

0.07

2.6

1.6

nmol/l

1.4

4.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

579

1.04

0.07

1.5

1.3

—

(3044927) Protein electrophoresis panel - Urine

101

0.89

0.06

2.6

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

305

1.05

0.06

1.2

1.3

ug/l

3.7

3.8

0.04

281

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

105

0.86

0.06

1.4

1.5

—

(21494755) Public health laboratory ask at order entry panel

186

1833

1.02

0.06

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

304

0.95

0.05

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

253

0.95

0.05

1.3

1.0

u/ml

1.7

2.0

0.29

119

(3025130) Human papilloma virus identified in Specimen

267

1.05

0.05

1.6

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

124

1219

1.02

0.05

2.1

2.6

ug/l

0.6

0.7

0.96

700

(40768441) Liver Pathology biopsy report

110

1.09

0.05

1.6

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

248

1.05

0.05

1.6

1.4

mmol/l

7.3

7.1

0.13

172

(3027944) Amphetamines [Presence] in Urine

104

1057

0.98

0.04

1.9

2.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

160

1.06

0.04

1.2

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

141

1.06

0.03

1.6

1.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

102

1006

1.01

0.03

1.7

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

339

0.97

0.02

2.0

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

272

1.03

0.02

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

288

0.97

0.02

2.1

2.4

ug/min

96.6

120.0

0.15

181

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

107

0.93

0.02

1.0

1.1

mg/l

273.1

295.2

—

(3045142) Bone marrow Pathology biopsy report

123

1.06

0.01

1.1

1.3

—

(3027008) Opiates [Presence] in Urine

108

1072

1.01

0.01

1.8

2.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

114

1.05

0.00

1.3

1.4

nmol/l

43.3

31.5

0.61

(3000764) Benzodiazepines [Presence] in Urine

106

1066

0.99

0.00

1.9

2.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

125

1.04

0.00

2.5

3.0

u/ml

22.5

52.2

1.11

125

(40768793) Breast Pathology biopsy report

355

1.01

0.00

1.3

—

(3028300) Cannabinoids [Presence] in Urine

108

1075

1.00

0.00

1.9

2.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

126

1.03

0.00

1.1

1.2

u/l

57.4

52.5

—

(3051611) Lipemic interference index of Serum or Plasma

132

0.98

0.00

6.2

3.2

—

(4281824)

153

0.98

0.00

1.0

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

193

0.98

0.00

1.1

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

193

0.98

0.00

1.4

1.6

mmol/l

7.7

7.5

0.07

114

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.0

1.8

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

3.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

1.3

—

1234.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

2.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.85

0.00

4.6

2.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.01

0.00

1.2

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(4212803)

0.00

0.0

1.0

—

(3051651) Icteric interference index of Serum or Plasma

0.93

0.00

8.3

3.5

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1500.8

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

0.96

0.00

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

0.0

1.0

—

2.4

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.0

1.1

—

(3013762) Body weight Measured

0.00

0.0

1.6

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

30.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.85

0.00

4.6

2.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.90

0.00

1.1

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.8

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.0

—

71.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

0.96

0.00

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.98

0.00

1.7

2.1

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

2.0

—

1.4

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.01

0.00

1.3

1.6

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

2.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.91

0.00

1.0

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.00

0.00

1.2

1.1

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.0

—

33.7

—

(3032641) Amino acids panel - Urine

0.00

0.0

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_CONJUNCTIVITISATOPIC and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_CONJUNCTIVITISATOPIC	0.871 [0.76, 0.99]	0.039
Birth year	0.999 [0.99, 1.01]	0.737

During the follow-up period (1.1.1998 — 31.12.2019), 495 out of 8736 females with H7_CONJUNCTIVITISATOPIC died.

Males

Parameter	HR [95% CI]	p-value
H7_CONJUNCTIVITISATOPIC	1.134 [0.97, 1.32]	0.106
Birth year	0.994 [0.98, 1.0]	0.205

During the follow-up period (1.1.1998 — 31.12.2019), 326 out of 7543 males with H7_CONJUNCTIVITISATOPIC died.

Mortality risk

Mortality risk for people of age

years, who have H7_CONJUNCTIVITISATOPIC.

N-year risk	Females	Males
1	0.104%	0.293%
5	0.654%	1.533%
10	1.512%	3.981%
15	2.959%	7.591%
20	5.068%	12.889%

Relationships between endpoints

↥

Index endpoint: H7_CONJUNCTIVITISATOPIC – Atopic conjunctivitis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Atopic conjunctivitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints